Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1998, p. 3737-3739, Vol. 36, No. 12
PanBio Pty Ltd.,
Received 18 June 1998/Returned for modification 8 July
1998/Accepted 1 September 1998
Saliva was collected prospectively from patients presenting with
suspected dengue infection 4 to 8 days after the onset of symptoms and
assayed by a commercial dengue immunoglobulin M (IgM) and IgG capture
enzyme-linked immunosorbent assay (ELISA) (PanBio Dengue Duo ELISA).
Laboratory diagnosis was based on virus isolation and on
hemagglutination inhibition (HAI) assay and an in-house IgM and IgG
capture ELISA. With a positive result defined as either salivary IgM or
IgG levels above the cutoff value, an overall sensitivity of 92% was
obtained for both primary- and secondary-dengue patients (22 of 24),
while no patients with non-flavivirus infections (n = 11) and no healthy laboratory donors (n = 17) showed
elevation of salivary antidengue antibody (100% specificity). Salivary
IgG levels correlated well with serum HAI titer (r = 0.78), and salivary IgG levels could be used to distinguish between
primary- and secondary-dengue virus infections.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Detection of Specific Antibodies in Saliva during
Dengue Infection

*
Corresponding author. Mailing address: PanBio Pty Ltd.,
116 Lutwyche Rd., Windsor, Queensland 4030, Australia. Phone:
61-7-33571177. Fax: 61-7-33571222. E-mail:
peter_devine{at}panbio.com.au.
Present address: Department of Virus Diseases, Walter Reed Army
Institute of Research, Washington, D.C.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»